Related references
Note: Only part of the references are listed.Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic
Ranjana Bhandari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia et al.
LANCET INFECTIOUS DISEASES (2021)
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
J. Sadoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Jing-Hui Tian et al.
NATURE COMMUNICATIONS (2021)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Hao Xu et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)
The promise of mRNA vaccines: a biotech and industrial perspective
Nicholas A. C. Jackson et al.
NPJ VACCINES (2020)
Potential Implications of Testing an Experimental mRNA-Based Vaccine During an Emerging Infectious Disease Pandemic
Ariadne A. Nichol
AMERICAN JOURNAL OF BIOETHICS (2020)
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Yixuan J. Hou et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process
Hao Zhang et al.
GUT (2020)
The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world
Hannah R. Sharpe et al.
IMMUNOLOGY (2020)
Site-specific glycan analysis of the SARS-CoV-2 spike
Yasunori Watanabe et al.
SCIENCE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
Jean-Michel Sallenave et al.
FRONTIERS IN IMMUNOLOGY (2020)
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
Zou Xin et al.
FRONTIERS OF MEDICINE (2020)
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers
Prabhu S. Arunachalam et al.
NATURE MEDICINE (2020)
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat et al.
NATURE MEDICINE (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
Jieliang Wang et al.
AAPS PHARMSCITECH (2020)
The Natural History and Transmission Potential of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Nguyen Van Vinh Chau et al.
CLINICAL INFECTIOUS DISEASES (2020)
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Hui Wang et al.
CELL (2020)
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai et al.
CELL (2020)
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang et al.
CELL (2020)
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
Runhong Zhou et al.
IMMUNITY (2020)
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
Dorottya Laczko et al.
IMMUNITY (2020)
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials
Shengli Xia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
Kenneth E. Remy et al.
JCI INSIGHT (2020)
Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In Vivo
Chunxi Zeng et al.
ADVANCED MATERIALS (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
Jing Lu et al.
CELL RESEARCH (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
mRNA vaccines: intellectual property landscape
Cecilia Martin et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cytokine storm induced by SARS-CoV-2
Peipei Song et al.
CLINICA CHIMICA ACTA (2020)
Can existing live vaccines prevent COVID-19?
Konstantin Chumakov et al.
SCIENCE (2020)
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
Supriya Ravichandran et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
Paul F. McKay et al.
NATURE COMMUNICATIONS (2020)
Vaccine Against Covid-19 Disease - Present Status of Development
Ashok Kumar Dutta
INDIAN JOURNAL OF PEDIATRICS (2020)
Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity
Wakako Sakaguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Gregory A. Poland et al.
LANCET (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines
Marc Gurwith et al.
VACCINE (2020)
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
Mimi Guebre-Xabier et al.
VACCINE (2020)
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
Rudra P. Saha et al.
FRONTIERS IN PHARMACOLOGY (2020)
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
Ekramy E. Sayedahmed et al.
VACCINES (2020)
Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection
Sang Heui Seo et al.
VACCINES (2020)
Covid-19: People with history of significant allergic reactions should not receive Pfizer vaccine, says regulator
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Covid-19: Pfizer and BioNTech submit vaccine for US authorisation
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Covid-19: Pfizer vaccine efficacy was 52% after first dose and 95% after second dose, paper shows
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
Sara E. Oliver et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2
Desh Deepak Singh et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
Desh Deepak Singh et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Zezhong Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Recent advances in vaccine and immunotherapy for COVID-19
Ali A. Rabaan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Transendothelial migration (TEM) of in vitro generated dendritic cell vaccine in cancer immunotherapy
Muhammad Umer Ashraf et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Dendritic Cell-Mediated Th2 Immunity and Immune Disorders
Sunil Kumar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Mucosal Vaccination via the Respiratory Tract
Marie Hellfritzsch et al.
PHARMACEUTICS (2019)
Caseload and Case Fatality of Lassa Fever in Nigeria, 2001-2018: A Specialist Center's Experience and Its Implications
George O. Akpede et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study
Carole Henry et al.
JOURNAL OF VIROLOGY (2019)
Fatal Zika virus infection in the Americas: A systematic review
Jaime A. Cardona-Ospina et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study
Muhammad Tahir Ul Qamar et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Novel viral vectors in infectious diseases
Ian R. Humphreys et al.
IMMUNOLOGY (2018)
Plant-produced Recombinant Influenza A Vaccines Based on the M2e Peptide
Eugenia S. Mardanova et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Intranasal immunization with dry powder vaccines
Tania F. Bahamondez-Canas et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
Annette B. Vogel et al.
MOLECULAR THERAPY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Acceptability of intranasal live attenuated influenza vaccine; influenza knowledge and vaccine intent in The Gambia
Edwin T. Armitage et al.
VACCINE (2018)
Immune responses after live attenuated influenza vaccination
Kristin G. -I. Mohn et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Noninvasive vaccination against infectious diseases
Zhichao Zheng et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation
Cristina Possas et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2018)
DNA VaccinesHow Far From Clinical Use?
Dominika Hobernik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl et al.
MOLECULAR THERAPY (2017)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
The Ebola outbreak, 2013-2016: old lessons for new epidemics
Cordelia E. M. Coltart et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008-2013
Wu Wendi et al.
VACCINE (2017)
Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines
Yuhong Xiao et al.
VACCINE (2017)
Current state and challenges in developing oral vaccines
Julia E. Vela Ramirez et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
Jasdave S. Chahal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets
Andrew J. Broadbent et al.
VACCINE (2016)
Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits
Azhar Choudhry et al.
VACCINE (2016)
An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
Margit Schnee et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Polio vaccination: past, present and future
Ananda S. Bandyopadhyay et al.
FUTURE MICROBIOLOGY (2015)
The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper
Neal A. Halsey et al.
VACCINE (2015)
Development of oral CTL vaccine using a CTP-integrated Sabin 1 poliovirus-based vector system
Seung-Soo Han et al.
VACCINE (2015)
Live attenuated vaccines: Historical successes and current challenges
Philip D. Minor
VIROLOGY (2015)
Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine
Jose M. Jimenez-Guardeno et al.
PLOS PATHOGENS (2015)
Influenza vaccines: from whole virus preparations to recombinant protein technology
Victor C. Huber
EXPERT REVIEW OF VACCINES (2014)
History of vaccination
Stanley Plotkin
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Dengue in the United States of America: A Worsening Scenario?
German Anez et al.
BIOMED RESEARCH INTERNATIONAL (2013)
The History of Dengue Outbreaks in the Americas
Olivia Brathwaite Dick et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Recombinant vaccines and the development of new vaccine strategies
I. P. Nascimento et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2012)
Waning Intestinal Immunity After Vaccination With Oral Poliovirus Vaccines in India
Nicholas C. Grassly et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
Benjamin Petsch et al.
NATURE BIOTECHNOLOGY (2012)
Live attenuated intranasal influenza vaccine
Susanna Esposito et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Potential of Nasopharynx-associated Lymphoid Tissue for Vaccine Responses in the Airways
Per Brandtzaeg
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Mortality Burden of the A/H1N1 Pandemic in Mexico: A Comparison of Deaths and Years of Life Lost to Seasonal Influenza
Vivek Charu et al.
CLINICAL INFECTIOUS DISEASES (2011)
A Review of Adult Mortality Due to 2009 Pandemic (H1N1) Influenza A in California
Janice K. Louie et al.
PLOS ONE (2011)
Mucosal immunity and poliovirus vaccines: Impact on wild poliovirus infection and transmission
Hiromasa Okayasu et al.
VACCINE (2011)
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Lanying Du et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Viruses as vaccine vectors for infectious diseases and cancer
Simon J. Draper et al.
NATURE REVIEWS MICROBIOLOGY (2010)
FluBlok, a next generation influenza vaccine manufactured in insect cells
Manon M. J. Cox et al.
BIOLOGICALS (2009)
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
P. Noel Barrett et al.
EXPERT REVIEW OF VACCINES (2009)
Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring
Claudia Vellozzi et al.
VACCINE (2009)
The 1918 Spanish Flu in Spain
Antoni Trilla et al.
CLINICAL INFECTIOUS DISEASES (2008)
FluBlok, a recombinant hemagglutinin influenza vaccine
Manon M. J. Cox et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2008)
Chikungunya-related fatality rates, Mauritius, India, and Reunion Island
Philippe Renault et al.
EMERGING INFECTIOUS DISEASES (2008)
Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara
CL Smith et al.
JOURNAL OF IMMUNOLOGY (2005)
Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: Role of ciliated cells in viral spread in the conducting airways of the lungs
AC Sims et al.
JOURNAL OF VIROLOGY (2005)
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence
CL Smith et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
The epidemic of West Nile virus in the United States, 2002
DR O'Leary et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2004)
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach
J Talon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections
J Sizun et al.
JOURNAL OF HOSPITAL INFECTION (2000)
Share Paper
